title: Levels of salivary lysozyme, lactoperoxidase, and lactoferrin in diabetic hamsters.
abstract: In an attempt to clarify the mechanism(s) of increased susceptibility to oral infection in diabetics, we examined the levels of salivary antibacterial factors, including lysozyme, lactoperoxidase, and lactoferrin, in diabetic hamsters whose condition was induced with streptozotocin. Saliva was collected from these hamsters periodically for 19 weeks after the administration of streptozotocin. Diabetes persisted with significant hyperglycemia throughout the experiment after a single injection of streptozotocin. There was no significant difference between groups in the amount of saliva secreted. In diabetic hamsters, lysozyme activity decreased by 56% and lactoperoxidase activity decreased by 53% compared with the control hamsters 19 weeks after the administration of streptozotocin. There was no significant difference between groups in the amount of salivary lactoferrin. However, the ratio of lactoferrin to total protein increased to approximately double the amount of that of the control hamsters. Insulin treatment had a significant effect on lysozyme and lactoperoxidase activity, recovering 73 and 74% those of the controls, respectively, and the ratio of lactoferrin to total salivary protein reverted to normal values. Growth inhibition of Lactobacillus plantarum ATCC 8014 with whole saliva and amylase activity significantly decreased in diabetic hamsters. The position of each protein band of whole saliva on sodium dodecyl sulfate-polyacrylamide gel electrophoresis was almost the same for control and diabetic hamsters; however, there was some variability in band intensity.
authors.forename: K
authors.initials: K
authors.lastname: Muratsu
authors.forename: T
authors.initials: T
authors.lastname: Morioka
mesh_terms: D000681:Amylases / Q000378:metabolism; D000818:Animals; D006224:Cricetinae; D003921:Diabetes Mellitus, Experimental / Q000201:enzymology / Q000378:metabolism*; D004591:Electrophoresis, Polyacrylamide Gel; D007328:Insulin / Q000494:pharmacology; D007778:Lactobacillus / Q000254:growth & development; D007781:Lactoferrin / Q000032:analysis*; D007782:Lactoglobulins / Q000032:analysis*; D007784:Lactoperoxidase / Q000378:metabolism*; D008297:Male; D008647:Mesocricetus; D009113:Muramidase / Q000378:metabolism*; D010544:Peroxidases / Q000378:metabolism*; D011506:Proteins / Q000032:analysis; D012463:Saliva / Q000032:analysis* / Q000201:enzymology / Q000378:metabolism; D013311:Streptozocin
chemical_list: D007328:Insulin; D007782:Lactoglobulins; D011506:Proteins; D013311:Streptozocin; D007784:Lactoperoxidase; D010544:Peroxidases; D000681:Amylases; D009113:Muramidase; D007781:Lactoferrin